- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 21st, 2008
Mansoor Amiji is working on finding a way to deliver drugs to cancer patients using nanomedicine.
Amiji, 44, an associate department chairman in the Pharmaceutical Sciences Department at Northeastern University's School of Pharmacy, is involved with a research group funded by the National Institutes of Health and the National Cancer Institute for the project, which involves the combination of nanotechnology and medicine to treat cancer patients.
Nanomedicine treats diseases, like cancer, at the molecular level, said Amiji. Such technology could be used as a way to target the sick part of a person's body, delivering medicine to the diseased area without harming the rest of the body, he said. In nanomedicine, drugs are delivered to cancer cells through nanoparticles, which are so small that they are able to penetrate through to the protein and DNA inside of the cells of diseased tissues. They are designed to carry anti-cancer drugs and bring that medication all the way to the diseased cells in a person's body without harming the healthy cells.
|Related News Press|
News and information
Stealth nanocapsules kill Chagas parasites in mouse models June 22nd, 2016